Language: Spanish
References: 97
Page: 41-74
PDF size: 239.89 Kb.

Text Extraction

No abstract

REFERENCES

1. Martínez MC, Quintana SG, Ambriz FR. Tópicos selectos en medicina transfusional. Editorial Prado 2002.

2. Malagón MMI. Consenso nacional para el uso de sangre y sus componentes. Gac Med Mex 2002;138(Supl 1);35-37.

3. Consenso de expertos en medicina transfusional. Recomendaciones para las transfusiones de sangre. Agrupación Mexicana para el Estudio de la Hematología; 2001.

4. Ambriz FR, Baptista GH, Benitez AH, et al. Indicaciones para la práctica transfusional en pediatría. Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social; 2001.

5. Consenso de Expertos en Medicina Transfusional. Recomendaciones para la terapia transfusional de sangre y sus componentes. Agrupación Mexicana para el Estudio de la Hematología; 2001.

6. Triuilzi DJ. Blood transfusión therapy a phisician handbook.7th ed. AABB.2002;1-15;62-82.

7. Guide to the preparation, use and quality assurance of blood components, Council of Europe. 8th ed. Publishing; 2002.

8. Manual de transfusión del Comité del Hospital de la Princesa. Comunidad de Madrid, España: INSALUD; 2001.

9. Hillyer D, et al. Blood banking and tansfusion medicine. Basic principles and practice. Churchill Livingstone; 2003.

10. Blood Transfusion Task Force. Guidelines for the clinial use of red cell transfusions.British Committee for Standars in Haematology; 2001.

11. Blood transfusion Transfucion Task Force. Transfusion guidelines for the neonatal and older children. British Committee for Standards in Haematology; 2003.

12. Isbister PJ. Decision marking in perioperative transfusion. Transfus Apheresis Sci 2002;27:19-28.

13. Esber NW. Massive blood transfusion in the elective surgical setting .Transfusion and Apheresis Science 2002;27:83-92.

14. Roseff SD, Luban NC, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002;42:1398-413.

15. Brecher ME. editor. Technical manual .14Th ed. Bethesda, MD, USA: American Association of Blood Banks; 2002.

16. Pimentel AG. Los Testigos de Jehová y el consentimiento informado. Rev Med IMSS 2002;40:495-504.

17. Advanced Trauma Life Support Subcommittee, American College of Surgeons. Br J Hematol 2001;113:24-31.

18. Consenso de Expertos en Medicina Transfusional. Recomendaciones para la terapia transfusional de sangre y sus componentes. Agrupación Mexicana para el Estudio de la Hematología. 2001

19. Triuilzi DJ. Blood Transfusion therapy a physician handbook.7th Ed. AABB.2002;1-15:62-82.

20. Council of Europe Publishing, 8th ed. Guide to the preparation, use and quality assurance of blood components, 2002.

21. Manual de transfusión del Comité del Hospital de la Princesa. Madrid; España: INSALUD; 2001.

22. Hillyer DC, et al. Blood banking and transfusion medicine. Basic Principles and practice. Churchill Livingstone; 2003.

23. Blood transfusion Task Force. Guidelines for the clinical use of red cell transfusions. British Committee for Standards in Hematology. 2001.

24. Blood Transfusion Task Force. Transfusion guidelines for the neonatal and older children. British Committee for Standards in Hematology; 2003.

25. Isbister PJ. Decision marking in perioperative transfusion. Transfusion Apheresis Sc 2002;27:19–28.

26. Esber NW. Massive blood transfusion in the elective surgical setting. Transfusion and Apheresis Sc 2002;27:83-92.

27. Roseff SD, Luban NC, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002;42:1398-413.

28. Brecher ME, editor. Technical manual. 14Th ed. Bethesda, MD, USA: American Association of Blood Banks; 2002.

29. Pimentel AG. Los Testigos de Jehová y el consentimiento informado. Rev Med IMSS 2002;40:495-504.

30. Advanced Trauma Life Support Subcommittee, American College of Surgeons. Br J Hematol 2001;113:24-31.

31. Recomendaciones para la terapia transfusional de sangre y sus componentes: consenso de expertos en medicina transfusional. Comité de Medicina Transfusional de la Agrupación Mexicana para el Estudio de la Hematología. México 2001.

32. Council of Europe Publishing, 8th ed. Guide to the preparation use and quality assurance of blood components, 2002.

33. Brecher ME. editor. Technical manual, 14 th ed. Bethesda, MD, American Association of Blood Banks; 2002.

34. Indicaciones para la práctica transfusional en pediatría. México: Instituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Coordinación de Atención Médica, 2001.

35. Menitove JE, Snyder ED. Platelet transfusion practice: time for renewed consensus. Transfusion 1998;38:707-709.

36. Contreras M. Final statement from the Consensus Conference on Platelet Transfusion. Transfusion 1998;38:796-7.

37. Weiss D, Mintz P. The evaluation and management of platelet refractoriness and alloimmunization. Transfus Med Rev 2000;14:180-196.

38. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer. Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1519-38.

39. NIH Consensus Development Conference. Platelet transfusion therapy. JAMA 1987;257:1777-1780.

40. Kickler TS, Herman JH. Current tissues in platelet transfusion therapy and platelet alloimmunity. Bethesda, MD,USA: American Association of Blood Banks 1999.

41. Chang H, Hawes J, Hall GA, et al. Prospective audit of Cytomegalovirus negative blood products utilization in Hematology Oncology patients. Transfus Med 1999;9:195-198.

42. Kao JK, Mickel M, Braine HG et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group. Transfusion 2000;40:1457-1462.

43. Alving BM. Platelet substitutes: the reality and the potential. Vox Sang 2002;83:287-88.

44. Benjamin RJ, Anderson KC. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol 2002;42:163-171.

45. Navarro JT, et al. Prophylactic platelet transfusion thereshold during therapi for adult acute myeloid leukemia: 10,000 micro versus 20,000/microL. Hematologica 1998;83:998-1000.

46. Callow CR, et al. The frequency of bleeding complications in patients with hematological malignancy following the introduction of a stringent prophylactic platelet transfusión policy. Br J Hematol 2002;118:677-682.

47. Roberts IAG, Murray NE. Management of thrombocytopenia in Neonates. Br J Haematol 1999;105:864-870.

48. Atoyebi W, et al. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD positive platelet concentrates? Br J Hematol 2000;111:980-983.

49. Roseff SD et al. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002;42:1398-1412.

50. Ranasinghe E et al. Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Hematol 2001;113:40-42.

51. Nuttal GA, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773-781.

52. Rebulla P. Trigger for platelet transfusion. Vox Sang 2000;78:179-182.

53. Norma Oficial Mexicana NOM-003-SSA2-1993 para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación. 18 de julio de 1994.

54. Mintz DP. editor. Transfusion therapy: clinical principles and practice, 1st ed. Bethesda; MD, USA: American Association of Blood Banks; 1999.

55. Brecher ME. editor. Technical manual .14Th ed. Bethesda, MD, USA: American Association of Blood Banks; 2002.

56. Menitove JE. editor. Standards for blood banks and transfusion services, 20th editor. Bethesda, MD, USA: American Association of Blood Banks; 2000.

57. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine blood. 10th ed. Oxford: Blackwell Scientific Pubications; 1997 (reprinterd) 1998.

58. Council of Europe Publishing, 8th ed. Guide to the preparation,use and quality assurance of blood components, 2002.

59. Darell JT. Blood transfusion therapy. A Physicians Handbook. 6th ed. Bethesda, MD, USA: American Association of Blood Banks; 1999.

60. Friedberg RC. Transfusion I: Issues in Transfusion Therapy in the patient with malignancy and transplantation, Hematology/Oncology Clinics of North America 8(6)1223-53,1994.

61. Indicaciones para la práctica transfusional en Pediatría. Instituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas, Coordinación de Atención Médica, 2001.

62. Radillo GA. Medicina transfusional, ed Prado; 1999.

63. NIH consensus development conference. Fresh frozen plasma: indications and risk. JAMA 1985;253:551-3.

64. Cohen H, Kernoff PA. Plasma, plasma products, and indications for their use. Br Med J 1990;300:803-806.

65. Contreras M, et al. Guidelines for use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusions Task Force. Transfus Med 1992;2:57-63.

66. College of American Pathologist. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets. JAMA 1994;271:777-81.

67. The United States Pharmacopeial convention, Inc. Hemophilia management. Transfus Med Rev 1998;12:128-140.

68. American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guideline for blood component therapy. Anesthesiology 1996;84:732-747.

69. Norma Oficial Mexicana NOM-003-SSA2-1993 Para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación. 18 de julio de 1994.

70. Mintz DP. ed. Transfusion therapy: Clinical principles and practice, 1a. ed. Bethesda;MD, USA: American Association of Blood Banks; 1999.

71. Brecher ME. ed. Technical manual. 14Th ed. Bethesda, MD, USA: American Association of Blood Banks; 2002.

72. Menitove JE. ed. Standards for blood banks and transfusion services, 20th ed. Bethesda, MD, USA: American Association of Blood Banks; 2000.

73. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine blood. 10th ed. Oxford: Blackwell Scientific Pubications. 1997 (reimpresión) 1998.

74. Council of Europe Publishing, 8th ed. Guide to the preparation, use and quality assurance of blood components, 2002.

75. Darell JT. Blood transfusion therapy. A Physicians Handbook. 6th ed. Bethesda, MD, USA: American Association of Blood Banks; 1999.

76. Radillo GA. Medicina Transfusional, ed Prado 1999.

77. Ambriz FR, Martínez MC, Quintana GS. Precauciones en el manejo de sangre y sus componentes. En: Navarrete S, Muñoz O, Santos PI, Infecciones Intrahospitalarias en Pediatría. MacGrow-Hill Interamericana 1998:241-257.

78. Contreras M. Final statement from the consensus conference on platelet transfusión. Transfusion 1998;38:796-797.

79. Kickler T. Pretransfusion testing for platelet transfusions. Transfusion 2000;40:1425-146.

80. Colman RW, Hirsh J, Marder BJ et al. eds. Hemostasis and Thrombosis: Basic principles and clinical practice. 3rd ed. Philadelphia: J.B. Lippicontt Company;1994.

81. Cohen H, Kernoff PA. Plasma, plasma products, and indications for their use. BJM 1990;300:803-806.

82. Contreras M, et al. Guidelines for use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusions Task Force. Transfus Med 1992;2:57-63.

83. Sweeney DJ, Rizk Y. Clinical Transfusion Medicine. Landes Bioscience 1999:112-5.

84. Reglamento de la Ley General de Salud en materia de control sanitario de la disposición de órganos, tejidos y cadáveres de seres humanos.

85. Reglamento de la Ley General de Salud en materia de prestaciones de servicios de atención médica.

86. College of American Pathologist. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets. JAMA 1994;271:777-781.

87. The United States Pharmacopeial convention, Inc. Hemophilia management. Transfus Med Rev 1998;12:128-140.

88. American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guideline for blood component therapy. Anesthesiology 1996;84:732-747.

89. Popovsky MA. Transfusion Reactions. Bethesda Maryland, MD, USA; American Association of Blood Banks, 1996.

90. Norma Oficial Mexicana NOM-003-SSA2-1993 Para la disposición de sangre humana y sus componentes con fines terapéuticos. Diario Oficial de la Federación. 18 de julio de 1994.

91. Mintz DP. ed. Transfusion therapy: Clinical principles and practice, 1a. ed. Bethesda; MD, USA: American Association of Blood Banks; 1999.

92. Council of Europe Publishing, 8th ed. Guide to the preparation use and quality assurance of blood components, 2002.

93. Menitove JE. editor. Standards for blood banks and transfusion services, 20th ed. Bethesda, MD, American Association of Blood Banks; 2000.

94. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine blood. 10th ed. Oxford: Blackwell Scientific Pubications. 1997 (reimpresión) 1998.

95. Brecher ME. editor. Technical manual, 13 ed. Bethesda, MD, USA: American Association of Blood Banks. 2002.

96. Darell JT. Blood transfusion rherapy. A physicians handbook. 6th ed. Bethesda, MD, USA: American Association of Blood Banks; 1999.

97. Radillo GA. Medicina transfusional. 1ª ed. México: Ed Prado, 1999.